Filter

Refine by date

—

Refine by collections

  • Print
  • Save

Search Results

You are looking at 1 - 10 of 188 items for :

  • Quality of life x
Clear All
Torquil Watt Department of Endocrinology, Copenhagen University Hospital Rigshospitalet
Institute of Public Health, University of Copenhagen

Search for other papers by Torquil Watt in
Google Scholar
PubMed Close
,
Laszlo Hegedüs Department of Endocrinology and Metabolism, Odense University Hospital, Odense, Denmark

Search for other papers by Laszlo Hegedüs in
Google Scholar
PubMed Close
,
Jakob Bue Bjorner Institute of Public Health, University of Copenhagen
National Research Centre for the Working Environment, Copenhagen

Search for other papers by Jakob Bue Bjorner in
Google Scholar
PubMed Close
,
Mogens Groenvold Institute of Public Health, University of Copenhagen
Department of Palliative Medicine, Bispebjerg Hospital

Search for other papers by Mogens Groenvold in
Google Scholar
PubMed Close
,
Steen Joop Bonnema Department of Endocrinology and Metabolism, Odense University Hospital, Odense, Denmark

Search for other papers by Steen Joop Bonnema in
Google Scholar
PubMed Close
,
Åse Krogh Rasmussen Department of Endocrinology, Copenhagen University Hospital Rigshospitalet

Search for other papers by Åse Krogh Rasmussen in
Google Scholar
PubMed Close
, and
Ulla Feldt-Rasmussen Department of Endocrinology, Copenhagen University Hospital Rigshospitalet

Search for other papers by Ulla Feldt-Rasmussen in
Google Scholar
PubMed Close

thyroid diseases, this area represents obvious beneficial applications. Thyroid diseases such as autoimmune hypothyroidism are common, chronic, and affect the patients’ function and quality of life (QoL) [ 2 , 3 ]. Despite this high prevalence, few

Article Type:
Research Article
DOI:
https://doi.org/10.1159/000342623
Volume/Issue:
Volume 1: Issue 3
Free access
Laura Moss Velindre Cancer Centre, Velindre University NHS Trust, Cardiff, United Kingdom

Search for other papers by Laura Moss in
Google Scholar
PubMed Close
,
Catrin Cox Centre for Trials Research, Cardiff University, Cardiff, United Kingdom

Search for other papers by Catrin Cox in
Google Scholar
PubMed Close
,
Jonathan Wadsley Weston Park Cancer Centre, Sheffield, United Kingdom

Search for other papers by Jonathan Wadsley in
Google Scholar
PubMed Close
,
Kate Newbold The Royal Marsden NHS Foundation Trust, London, United Kingdom

Search for other papers by Kate Newbold in
Google Scholar
PubMed Close
,
Mark W.J. Strachan Western General Hospital, Edinburgh, United Kingdom

Search for other papers by Mark W.J. Strachan in
Google Scholar
PubMed Close
,
Maralyn Druce Barts and the London School of Medicine and Dentistry, London, United Kingdom

Search for other papers by Maralyn Druce in
Google Scholar
PubMed Close
,
Neil Tolley Imperial College Healthcare NHS Trust, London, United Kingdom

Search for other papers by Neil Tolley in
Google Scholar
PubMed Close
,
Kathryn Graham Beatson Oncology Centre, Glasgow, United Kingdom

Search for other papers by Kathryn Graham in
Google Scholar
PubMed Close
,
Sarah Jefferies Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom

Search for other papers by Sarah Jefferies in
Google Scholar
PubMed Close
,
Lydia Fresco University Hospitals Coventry and Warwickshire NHS Trust, Coventry, United Kingdom

Search for other papers by Lydia Fresco in
Google Scholar
PubMed Close
,
Suganya Sivabalasingham University College Hospital NHS Foundation Trust, London, United Kingdom

Search for other papers by Suganya Sivabalasingham in
Google Scholar
PubMed Close
,
Alistair Balfour East Kent Hospitals University NHS Foundation Trust, Canterbury, United Kingdom

Search for other papers by Alistair Balfour in
Google Scholar
PubMed Close
, and
Chris Hurt Centre for Trials Research, Cardiff University, Cardiff, United Kingdom

Search for other papers by Chris Hurt in
Google Scholar
PubMed Close

). Patients with MEN2A and MEN2B have additional, associated medical conditions, e.g., phaeochromocytoma and hyperparathyroidism, which can impact on their quality of life (QoL). Patients with rare cancers can face additional barriers and concerns including

Article Type:
Research Article
DOI:
https://doi.org/10.1159/000509227
Volume/Issue:
Volume 10: Issue 1
Free access
Luba Freja Michaelsson Department of Endocrinology, Herlev Hospital, University of Copenhagen, Copenhagen, Denmark

Search for other papers by Luba Freja Michaelsson in
Google Scholar
PubMed Close
,
Jeppe Lerche  la Cour Department of Endocrinology, Herlev Hospital, University of Copenhagen, Copenhagen, Denmark

Search for other papers by Jeppe Lerche  la Cour in
Google Scholar
PubMed Close
,
Bjarke Borregaard Medici Department of Endocrinology, Herlev Hospital, University of Copenhagen, Copenhagen, Denmark

Search for other papers by Bjarke Borregaard Medici in
Google Scholar
PubMed Close
,
Torquil Watt Department of Endocrinology, Herlev Hospital, University of Copenhagen, Copenhagen, Denmark

Search for other papers by Torquil Watt in
Google Scholar
PubMed Close
,
Jens Faber Department of Endocrinology, Herlev Hospital, University of Copenhagen, Copenhagen, Denmark
Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark

Search for other papers by Jens Faber in
Google Scholar
PubMed Close
, and
Birte Nygaard Department of Endocrinology, Herlev Hospital, University of Copenhagen, Copenhagen, Denmark
Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark

Search for other papers by Birte Nygaard in
Google Scholar
PubMed Close

patients have a severely decreased quality of life (QoL). After the initiation of L-T 4 monotherapy, QoL is greatly improved; however, it remains somewhat decreased compared to the general population [ 4 ]. QoL for patients receiving L-T 4 /L-T 3

Article Type:
Research Article
DOI:
https://doi.org/10.1159/000490383
Volume/Issue:
Volume 7: Issue 5
Free access
Camilla Bøgelund Larsen Department of Endocrinology, Odense University Hospital, Denmark
Department of Clinical Research, University of Southern Denmark, Odense, Denmark

Search for other papers by Camilla Bøgelund Larsen in
Google Scholar
PubMed Close
,
Kristian Hillert Winther Department of Clinical Research, University of Southern Denmark, Odense, Denmark

Search for other papers by Kristian Hillert Winther in
Google Scholar
PubMed Close
,
Per Karkov Cramon Department of Clinical Physiology and Nuclear Medicine, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark

Search for other papers by Per Karkov Cramon in
Google Scholar
PubMed Close
,
Åse Krogh Rasmussen Department of Endocrinology and Metabolism, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark

Search for other papers by Åse Krogh Rasmussen in
Google Scholar
PubMed Close
,
Ulla Feldt-Rasmussen Department of Endocrinology and Metabolism, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark
Institute of Clinical Medicine, Faculty of Health and Clinical Sciences, Copenhagen University, Copenhagen, Denmark

Search for other papers by Ulla Feldt-Rasmussen in
Google Scholar
PubMed Close
,
Nils Jakob Knudsen Department of Endocrinology, Bispebjerg University Hospital, Copenhagen, Denmark

Search for other papers by Nils Jakob Knudsen in
Google Scholar
PubMed Close
,
Jakob Bue Bjorner Department of Public Health, Copenhagen University, Copenhagen, Denmark
QualityMetric Inc, Johnston, Lincoln, Rhode Island, USA

Search for other papers by Jakob Bue Bjorner in
Google Scholar
PubMed Close
,
Lutz Schomburg Institute for Experimental Endocrinology, Charité Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany

Search for other papers by Lutz Schomburg in
Google Scholar
PubMed Close
,
Kamil Demircan Institute for Experimental Endocrinology, Charité Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany

Search for other papers by Kamil Demircan in
Google Scholar
PubMed Close
,
Thilo Samson Chillon Institute for Experimental Endocrinology, Charité Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany

Search for other papers by Thilo Samson Chillon in
Google Scholar
PubMed Close
,
Jeppe Gram Medical Department, Endocrinology, University Hospital of South-West Jutland, Esbjerg, Denmark

Search for other papers by Jeppe Gram in
Google Scholar
PubMed Close
,
Stinus Gadegaard Hansen Medical Department, Endocrinology, University Hospital of South-West Jutland, Esbjerg, Denmark

Search for other papers by Stinus Gadegaard Hansen in
Google Scholar
PubMed Close
,
Frans Brandt Department of Clinical Research, University of Southern Denmark, Odense, Denmark
Internal Medicine Research Unit, University Hospital of Southern Jutland, Aabenraa, Denmark

Search for other papers by Frans Brandt in
Google Scholar
PubMed Close
,
Birte Nygaard Department of Endocrinology, Herlev and Gentofte Hospital, University of Copenhagen, Copenhagen, Denmark

Search for other papers by Birte Nygaard in
Google Scholar
PubMed Close
,
Torquil Watt Department of Endocrinology and Metabolism, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark
Institute of Clinical Medicine, Faculty of Health and Clinical Sciences, Copenhagen University, Copenhagen, Denmark

Search for other papers by Torquil Watt in
Google Scholar
PubMed Close
,
Laszlo Hegedüs Department of Endocrinology, Odense University Hospital, Denmark
Department of Clinical Research, University of Southern Denmark, Odense, Denmark

Search for other papers by Laszlo Hegedüs in
Google Scholar
PubMed Close
, and
Steen Joop Bonnema Department of Endocrinology, Odense University Hospital, Denmark
Department of Clinical Research, University of Southern Denmark, Odense, Denmark

Search for other papers by Steen Joop Bonnema in
Google Scholar
PubMed Close

with adjusted dosage to normalise circulating thyrotropin (TSH) levels ( 3 ). However, despite adequate treatment, quality of life (QoL) remains impaired in a subset of patients ( 4 , 5 , 6 ), and excess morbidity and mortality persist ( 7 , 8 ). The

Article Type:
Research Article
Collections:
Hypothyroidism
DOI:
https://doi.org/10.1530/ETJ-23-0175
Volume/Issue:
Volume 13: Issue 1
Open access
Alice Nervo Oncological Endocrinology Unit, Department of Medical Sciences, University of Turin, Città della Salute e della Scienza Hospital, Turin, Italy

Search for other papers by Alice Nervo in
Google Scholar
PubMed Close
,
Alberto Ragni Oncological Endocrinology Unit, Department of Medical Sciences, University of Turin, Città della Salute e della Scienza Hospital, Turin, Italy

Search for other papers by Alberto Ragni in
Google Scholar
PubMed Close
,
Alessandro Piovesan Oncological Endocrinology Unit, Department of Medical Sciences, University of Turin, Città della Salute e della Scienza Hospital, Turin, Italy

Search for other papers by Alessandro Piovesan in
Google Scholar
PubMed Close
,
Valentina Marica Oncological Endocrinology Unit, Department of Medical Sciences, University of Turin, Città della Salute e della Scienza Hospital, Turin, Italy

Search for other papers by Valentina Marica in
Google Scholar
PubMed Close
,
Enrica Migliore Cancer Epidemiology Unit, Department of Medical Sciences, University of Turin, Città della Salute e della Scienza Hospital, Turin, Italy

Search for other papers by Enrica Migliore in
Google Scholar
PubMed Close
,
Marco Gallo Oncological Endocrinology Unit, Department of Medical Sciences, University of Turin, Città della Salute e della Scienza Hospital, Turin, Italy

Search for other papers by Marco Gallo in
Google Scholar
PubMed Close
, and
Emanuela Arvat Oncological Endocrinology Unit, Department of Medical Sciences, University of Turin, Città della Salute e della Scienza Hospital, Turin, Italy

Search for other papers by Emanuela Arvat in
Google Scholar
PubMed Close

trials [ 6 ]. Various instruments assessing health-related QoL, such as the European Quality of Life 5 Dimensions (EQ-5D) Questionnaire or the Functional Assessment of Cancer Therapy – General, have been employed to investigate the impact of anticancer

Article Type:
Research Article
DOI:
https://doi.org/10.1159/000508186
Volume/Issue:
Volume 10: Issue 1
Free access
Milan Halenka Department of Internal Medicine III – Nephrology, Rheumatology and Endocrinology, University Hospital Olomouc, Olomouc, Czech Republic
Department of Internal Medicine III – Nephrology, Rheumatology and Endocrinology, Faculty of Medicine and Dentistry, Palacky University Olomouc, Olomouc, Czech Republic

Search for other papers by Milan Halenka in
Google Scholar
PubMed Close
,
Hana Munteanu Department of Internal Medicine III – Nephrology, Rheumatology and Endocrinology, Faculty of Medicine and Dentistry, Palacky University Olomouc, Olomouc, Czech Republic

Search for other papers by Hana Munteanu in
Google Scholar
PubMed Close
,
Radko Obereigneru Faculty of Arts, Palacky University Olomouc, Olomouc, Czech Republic

Search for other papers by Radko Obereigneru in
Google Scholar
PubMed Close
,
Roman Dohnal Department of Internal Medicine III – Nephrology, Rheumatology and Endocrinology, University Hospital Olomouc, Olomouc, Czech Republic
Department of Internal Medicine III – Nephrology, Rheumatology and Endocrinology, Faculty of Medicine and Dentistry, Palacky University Olomouc, Olomouc, Czech Republic

Search for other papers by Roman Dohnal in
Google Scholar
PubMed Close
,
David Karasek Department of Internal Medicine III – Nephrology, Rheumatology and Endocrinology, University Hospital Olomouc, Olomouc, Czech Republic
Department of Internal Medicine III – Nephrology, Rheumatology and Endocrinology, Faculty of Medicine and Dentistry, Palacky University Olomouc, Olomouc, Czech Republic

Search for other papers by David Karasek in
Google Scholar
PubMed Close
, and
Jan Schovanek Department of Internal Medicine III – Nephrology, Rheumatology and Endocrinology, University Hospital Olomouc, Olomouc, Czech Republic
Department of Internal Medicine III – Nephrology, Rheumatology and Endocrinology, Faculty of Medicine and Dentistry, Palacky University Olomouc, Olomouc, Czech Republic

Search for other papers by Jan Schovanek in
Google Scholar
PubMed Close

damage, thrombotisation and ischemisation). Reactive tissue fibrosis and slow cyst cavity crinkling follow ( 16 ). The effect of thyroid cysts and their therapy on patients’ subjective symptoms and health-related quality of life (QoL) is commonly

Article Type:
Research Article
Collections:
Goiter and thyroid nodules
DOI:
https://doi.org/10.1530/ETJ-23-0085
Volume/Issue:
Volume 12: Issue 5
Open access
Massimo Giusti Endocrine Unit, San Martino Polyclinic Hospital, Genoa, Italy
Department of Internal Medicine, University of Genoa, Genoa, Italy

Search for other papers by Massimo Giusti in
Google Scholar
PubMed Close
,
Stefano Gay Endocrine Unit, San Martino Polyclinic Hospital, Genoa, Italy
Department of Internal Medicine, University of Genoa, Genoa, Italy

Search for other papers by Stefano Gay in
Google Scholar
PubMed Close
,
Lucia Conte Endocrine Unit, San Martino Polyclinic Hospital, Genoa, Italy
Department of Internal Medicine, University of Genoa, Genoa, Italy

Search for other papers by Lucia Conte in
Google Scholar
PubMed Close
,
Francesca Cecoli Endocrine Unit, San Martino Polyclinic Hospital, Genoa, Italy

Search for other papers by Francesca Cecoli in
Google Scholar
PubMed Close
,
Lorenzo Mortara Endocrine Unit, San Martino Polyclinic Hospital, Genoa, Italy

Search for other papers by Lorenzo Mortara in
Google Scholar
PubMed Close
,
Lara Vera Endocrine Unit, San Martino Polyclinic Hospital, Genoa, Italy

Search for other papers by Lara Vera in
Google Scholar
PubMed Close
, and
Eleonora Monti Department of Internal Medicine, University of Genoa, Genoa, Italy

Search for other papers by Eleonora Monti in
Google Scholar
PubMed Close

Introduction In 2003, quality of life (QoL) was defined by Crevenna et al. [ 1 ] as “an individual’s perception of his or her position in life, in the context of the culture and value systems in which he or she lives, and in relation to his or

Article Type:
Research Article
DOI:
https://doi.org/10.1159/000501201
Volume/Issue:
Volume 9: Issue 5
Free access
Birte Nygaard Departments of Endocrinology, Herlev University Hospital, Herlev

Search for other papers by Birte Nygaard in
Google Scholar
PubMed Close
,
Lars Bastholt Department of Oncology, Odense University Hospital, Odense, Denmark

Search for other papers by Lars Bastholt in
Google Scholar
PubMed Close
,
Finn Noe Bennedbæk Departments of Endocrinology, Herlev University Hospital, Herlev

Search for other papers by Finn Noe Bennedbæk in
Google Scholar
PubMed Close
,
Tobias Wirenfeldt Klausen Departments of Haematology, Herlev University Hospital, Herlev

Search for other papers by Tobias Wirenfeldt Klausen in
Google Scholar
PubMed Close
, and
Jens Bentzen Departments of Oncology, Herlev University Hospital, Herlev

Search for other papers by Jens Bentzen in
Google Scholar
PubMed Close

recent publications, indicating a life expectancy close to the background population for low-risk patients [ 3 ]. These are typically younger patients with jobs and families. Therefore a possible decrease in treatment-related quality of life (QOL) will

Article Type:
Research Article
DOI:
https://doi.org/10.1159/000354803
Volume/Issue:
Volume 2: Issue 3
Free access
Elena Hoppe Department of Medicine I, Johannes Gutenberg University Medical Center, Mainz, Germany
Department of Paediatrics, Johannes Gutenberg University Medical Center, Mainz, Germany

Search for other papers by Elena Hoppe in
Google Scholar
PubMed Close
,
Alan Chun Hong Lee Department of Medicine I, Johannes Gutenberg University Medical Center, Mainz, Germany

Search for other papers by Alan Chun Hong Lee in
Google Scholar
PubMed Close
,
David Hoppe Department of Psychology, Technical University of Darmstadt, Darmstadt, Germany

Search for other papers by David Hoppe in
Google Scholar
PubMed Close
, and
George J. Kahaly Department of Medicine I, Johannes Gutenberg University Medical Center, Mainz, Germany

Search for other papers by George J. Kahaly in
Google Scholar
PubMed Close

well-characterized clinical manifestations [ 1 ], the significant impact of GO on quality of life (QoL) [ 9 ], psychological well-being [ 10 ] and socioeconomic burden [ 11 , 12 ] are being increasingly recognized. Across the whole disease spectrum [ 9

Article Type:
Research Article
DOI:
https://doi.org/10.1159/000508071
Volume/Issue:
Volume 9: Issue 6
Free access
Agneta Lindo Department of Endocrinology, Sahlgrenska University Hospital, Göteborg, Sweden
Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Göteborg, Sweden
The National Task Force in Hyperthyroidism, Swedish National System for Knowledge-Driven Management, Umeå, Sweden

Search for other papers by Agneta Lindo in
Google Scholar
PubMed Close
,
Anne Breikert The National Task Force in Hyperthyroidism, Swedish National System for Knowledge-Driven Management, Umeå, Sweden
Department of Endocrinology and Diabetes, Örebro University Hospital, Örebro, Sweden

Search for other papers by Anne Breikert in
Google Scholar
PubMed Close
,
Peter Lakwijk The National Task Force in Hyperthyroidism, Swedish National System for Knowledge-Driven Management, Umeå, Sweden
Thyroid Federation International, Kungsbacka, Sweden

Search for other papers by Peter Lakwijk in
Google Scholar
PubMed Close
,
Christin Lundberg The National Task Force in Hyperthyroidism, Swedish National System for Knowledge-Driven Management, Umeå, Sweden
Swedish Thyroid Association, Stockholm, Sweden

Search for other papers by Christin Lundberg in
Google Scholar
PubMed Close
,
Katarina Lunner The National Task Force in Hyperthyroidism, Swedish National System for Knowledge-Driven Management, Umeå, Sweden
Swedish Thyroid Association, Stockholm, Sweden

Search for other papers by Katarina Lunner in
Google Scholar
PubMed Close
,
Birgitta Johansson Institute of Neuroscience and Physiology Department of Clinical Neuroscience, Sahlgrenska Academy, University of Gothenburg, Göteborg, Sweden

Search for other papers by Birgitta Johansson in
Google Scholar
PubMed Close
, and
Helena Filipsson Nyström Department of Endocrinology, Sahlgrenska University Hospital, Göteborg, Sweden
Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Göteborg, Sweden
The National Task Force in Hyperthyroidism, Swedish National System for Knowledge-Driven Management, Umeå, Sweden
Sweden and Wallenberg Center for Molecular and Translational Medicine, Västra Götaland Region, Göteborg, Sweden

Search for other papers by Helena Filipsson Nyström in
Google Scholar
PubMed Close

Introduction There are five concepts of central importance with respect to person-centered care (PCC) ( 1 , 2 ): patient needs, patient expectations, patient perception, patient care, and patient quality of life (QoL). According to the World

Article Type:
Review Article
Collections:
Hyperthyroidism and thyrotoxicosis
DOI:
https://doi.org/10.1530/ETJ-23-0010
Volume/Issue:
Volume 12: Issue 3
Open access